Investors lose their appetite for the obesity trade
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...
WIVB Buffalo on MSN10h
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
‘Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...
NBC New York4d
‘Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summers says
Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come ... he told CNBC's "Squawk Box Europe." "But the truth is, being on these medicines ...
The Conversation3d
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household ... In response to those reports, the European Medicines Agency conducted a review of all available data and ...
Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and more
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...
Obesity drug study points to effectiveness in curbing addictions
The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.